Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol for Dynamic Hyperinflation in iPAH
NCT02108743Phase 2Withdrawn
- Sponsor
- American Medical Association Foundation
- Start
- Jun 2014
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
A Phase 2 trial of albuterol dry powder inhaler in idiopathic pulmonary arterial hypertension (IPAH), familial pulmonary arterial hypertension (FPAH), sponsored by American Medical Association Foundation. Planned start Jun 2014; status: withdrawn.
02
Drugs
albuterol dry powder inhaler
03
Conditions
idiopathic pulmonary arterial hypertension (IPAH)familial pulmonary arterial hypertension (FPAH)
Beyond the preview
Go deeper on NCT02108743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108743.